- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 46.26M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 46.51M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 45.75M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $1.39M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $1.37M |
| Capex | Q1 2026 · Mar 31, 2026 | $2.05M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.29M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $87.38M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$29.77M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $816.14M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $864.9M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $744.26M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $608.8M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.28B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.25B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $14.02B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $13.88B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $15.3B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $15.13B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.60 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.61 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.21 |
| Net Income | Q1 2026 · Mar 31, 2026 | $30.04M |
| Net Income | Q1 2026 · Mar 31, 2025 | $9.72M |